Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

High levels of prolactin in the blood can be linked to widespread hair loss.

The supplement helps improve hair growth and reduce hair shedding.

A systematic approach is crucial for managing hair loss in women.

UV rays can cause a type of hair loss known as telogen alopecia.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Effective hair loss assessment requires a mix of precise measurement methods.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.

Yoga and Ayurveda, including stress management and herbal oil use, can potentially reduce hair loss and promote hair growth, with further research needed for therapy protocols.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Radiation-induced alopecia after angioembolization usually heals on its own and can look like other hair loss types, but patient history helps prevent misdiagnosis.

Low iron levels are strongly linked to chronic hair loss in women.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.